Using blood tests to improve cancer monitoring and treatment
Development and Deployment of Liquid Biopsies in Bench Research and Clinical Trials in the UW Circulating Biomarker Core
This study is working on a new blood test that can help find cancer markers, making it easier for patients to get personalized treatment and better monitoring of their cancer, all while using less invasive methods.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10978267 on NIH RePORTER |
What this research studies
This research focuses on developing and implementing liquid biopsies, which are blood tests that can detect cancer biomarkers. By utilizing innovative technologies, the study aims to make these tests more accessible for clinical trials and research at the University of Wisconsin Carbone Cancer Center and beyond. Patients may benefit from more accurate monitoring of their cancer and tailored treatment options based on the results of these minimally invasive tests. The research involves collaboration between bioengineering and cancer biology experts to enhance the sensitivity of these tests for detecting rare cancer-related substances.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with various types of cancer who are undergoing treatment or monitoring.
Not a fit: Patients with non-cancerous conditions or those who are not currently being treated for cancer may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and less invasive methods for monitoring cancer progression and treatment response.
How similar studies have performed: Previous research has shown promising results with liquid biopsy technologies, indicating potential for significant advancements in cancer monitoring.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Schehr, Jennifer L — University of Wisconsin-Madison
- Study coordinator: Schehr, Jennifer L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.